Company:  PAVMED INC. (PAVM)
Form Type:  PRE 14A
Filing Date:  6/1/2020 
CIK:  0001624326 
Address:  ONE GRAND CENTRAL PLACE
SUITE 4600
 
City, State, Zip:  NEW YORK, New York 10165 
Telephone:  212-949-4319 
Fiscal Year:  12/31 
Last Trade
Last Trade: 
$1.79  
Change: 
0.01 (0.56%)  
Trade Time: 
Sep 25  
Market Cap: 
$89.68M
Trade PAVM now with

© 2020  
Description of Business
PAVmed is a highly-differentiated multi-product technology medical device company organized to advance a broad pipeline of innovative medical technologies from concept to commercialization, employing a business model focused on capital efficiency and speed to market. Since inception on June 26, 2014, the Company's activities have focused on advancing its lead products towards regulatory approval and commercialization, protecting its intellectual property, and building its corporate infrastructure and management team. The Company operates in one segment as a medical device company with four operating divisions which include GI Health, Minimally Invasive Interventions, Infusion Therapy, and Emerging Innovations. As resources permit, we will continue to explore internal and external innovations that fulfill our project selection criteria without limiting ourselves to any target specialty or condition.
Register and access this filing in:     
  FORM PRE 14A
    NOTICE OF ANNUAL MEETING OF STOCKHOLDERS TO BE HELD ON JULY ...
    PROXY STATEMENT
    The November 2019 Alto Transaction Proposal
    The April 2020 Alto Transaction Proposal
    THE 2014 PLAN PROPOSAL
      Adjustments; Certain Transactions
      NAME AND TITLE
    Report of the Audit Committee
    Director Compensation
    EXECUTIVE OFFICER COMPENSATION
      COMPENSATION TABLE
    SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS
      BENEFICIAL OWNERS
    CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS
    STOCKHOLDER PROPOSALS AND NOMINATIONS